Invited Session 3: Current Controversies in Endovascular Therapy for PAD

Invited Session 3: Current Controversies in Endovascular Therapy for PAD 

This activity was presented at VAM2020. 

  • Cautious Continued Use of Paclitaxel-Eluting Devices in PAD Patients: Norman H. Kumins, MD 
  • Crossing CTOs: Devices and/or Alternative Access: Brian DeRubertis, MD
     

Learning Objectives

  • Discuss the use of paclitaxel-eluting devices in PAD patients.
  • Identify devices and alternative access for crossing CTOs.
  • Address arterialization management for no-option CLTI patients.
Course summary
Course opens: 
11/19/2020
Course expires: 
11/22/2024
Cost:
$0.00
Part of: 
VAM20 Collection
Rating: 
0
 
Status
Price
Title
Locked
$0.00Included
Invited Session 3: Current Controversies in Endovascular Therapy for PAD
Please login or register to take this course.

Price

Cost:
$0.00
Please login or register to take this course.